• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的血浆左旋多巴达峰时间延迟和胃排空受损。

Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.

机构信息

Pharmaceutical Unit, Sakura Medical Center, Toho University, Sakura, Japan.

出版信息

J Neurol Sci. 2012 Aug 15;319(1-2):86-8. doi: 10.1016/j.jns.2012.05.010. Epub 2012 May 25.

DOI:10.1016/j.jns.2012.05.010
PMID:22632782
Abstract

OBJECTIVES

Whereas delayed gastric emptying is believed to be a causative factor for producing delayed-on and motor fluctuation in Parkinson's disease (PD), few studies have directly measured levodopa pharmacodynamics and gastric emptying together. In order to determine the relationship, we measured these two parameters in a single PD patients cohort.

METHODS

Thirty-one patients with PD were enrolled in the study. They were 11 men and 20 women; age, 68.1 ± 7.8 years; disease duration, 4.2 ± 3.8 years; Unified Parkinson's Disease Rating Scale Part 3 Motor Score 18.37 ± 8.60; bowel movement <3 times a week in 20; all taking 301 mg ± 94 mg/day levodopa/carbidopa. All patients underwent levodopa pharmacokinetic study and the gastric emptying study using (13)C-octanoic acid expiration breath test. Statistical analysis was performed by Student's t-test and Mann-Whitney's U test.

RESULTS

Pharmacokinetic study showed that the plasma levodopa peak was at 2 hours in 42% (13/31 patients) whereas at 1 hour in 58% (18/31 patients), total of 50.7 ± 16.4 min (mean ± standard deviation) in all 31 patients. The gastric emptying study showed that T(max) ((13)C)>60 min was more common in patients with a plasma levodopa peak at 2 hours (14/18, 69%) than in those with a plasma levodopa peak at 1 hour (4/13, 22%) (p<0.05), total of 50.7 ± 16.4 min in all 31 patients.

CONCLUSION

We found a significant relationship between levodopa pharmacokinetics and gastric emptying in PD patients, suggesting that delayed gastric emptying is a causative factor for producing delayed-on in PD. Therefore, studies of improved gastric emptying in order to ameliorate delayed-on in PD are warranted.

摘要

目的

胃排空延迟被认为是导致帕金森病(PD)迟发性运动障碍和运动波动的一个原因,但很少有研究直接测量左旋多巴的药效动力学和胃排空。为了确定这种关系,我们在一组 PD 患者中同时测量了这两个参数。

方法

研究纳入了 31 例 PD 患者,其中男 11 例,女 20 例;年龄 68.1±7.8 岁;病程 4.2±3.8 年;统一帕金森病评定量表第 3 部分运动评分 18.37±8.60;每周排便<3 次者 20 例;均服用左旋多巴/卡比多巴 301±94mg/d。所有患者均行左旋多巴药代动力学研究和(13)C-辛酸呼气试验胃排空研究。采用 Student's t 检验和 Mann-Whitney's U 检验进行统计学分析。

结果

药代动力学研究显示,42%(13/31 例)患者的血浆左旋多巴峰在 2 小时,58%(18/31 例)患者的血浆左旋多巴峰在 1 小时,所有 31 例患者的总时间为 50.7±16.4min(均数±标准差)。胃排空研究显示,T(max)(13)C>60min 在血浆左旋多巴峰在 2 小时的患者中更为常见(18/18,69%),而在 1 小时的患者中则较少见(13/13,22%)(p<0.05),所有 31 例患者的总时间为 50.7±16.4min。

结论

我们发现 PD 患者的左旋多巴药代动力学和胃排空之间存在显著关系,提示胃排空延迟是 PD 迟发性运动障碍的一个原因。因此,有必要研究改善胃排空以改善 PD 的迟发性运动障碍。

相似文献

1
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.帕金森病患者的血浆左旋多巴达峰时间延迟和胃排空受损。
J Neurol Sci. 2012 Aug 15;319(1-2):86-8. doi: 10.1016/j.jns.2012.05.010. Epub 2012 May 25.
2
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.丘脑底核脑深部电刺激可改善帕金森病患者的胃排空。
Brain. 2012 May;135(Pt 5):1478-85. doi: 10.1093/brain/aws086. Epub 2012 Apr 19.
3
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.盐酸多奈哌齐与左旋多巴/卡比多巴联合用于帕金森病患者:多次口服给药后药代动力学变化及安全性评估
Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.
4
Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.胃滞留型缓释制剂中左旋多巴/卡比多巴在帕金森病患者体内的药代动力学。
J Clin Pharmacol. 2012 Jul;52(7):1069-77. doi: 10.1177/0091270011409232. Epub 2011 May 24.
5
Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.标准卡比多巴-左旋多巴与缓释卡比多巴-左旋多巴治疗帕金森病的比较:药代动力学和生活质量指标
Mov Disord. 1997 Sep;12(5):677-81. doi: 10.1002/mds.870120508.
6
Dietary herb extract rikkunshi-to ameliorates gastroparesis in Parkinson's disease: a pilot study.膳食草药提取物六君子汤改善帕金森病患者的胃轻瘫:一项试点研究。
Eur Neurol. 2014;71(3-4):193-5. doi: 10.1159/000355608. Epub 2014 Jan 21.
7
Irregular gastrointestinal drug absorption in Parkinson's disease.帕金森病中胃肠道药物吸收不规则。
Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):193-203. doi: 10.1517/17425255.4.2.193.
8
Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.胃排空对帕金森病患者左旋多巴药代动力学的影响。
Clin Neuropharmacol. 2006 Mar-Apr;29(2):61-7. doi: 10.1097/00002826-200603000-00001.
9
Delayed gastric emptying in Parkinson's disease.帕金森病患者的胃排空延迟。
Mov Disord. 2014 Jan;29(1):23-32. doi: 10.1002/mds.25708. Epub 2013 Oct 21.
10
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.在晚期帕金森病中 IPX066 与标准左旋多巴制剂的交叉比较。
Mov Disord. 2011 Oct;26(12):2246-52. doi: 10.1002/mds.23861. Epub 2011 Jul 13.

引用本文的文献

1
Dopaminergic signalling in gastrointestinal health and disease.胃肠道健康与疾病中的多巴胺能信号传导
Nat Rev Gastroenterol Hepatol. 2025 Sep 8. doi: 10.1038/s41575-025-01112-5.
2
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion.恩他卡朋抑制儿茶酚-O-甲基转移酶用于帕金森病及运动并发症患者:持续输注的新颖性
J Neural Transm (Vienna). 2025 Sep 2. doi: 10.1007/s00702-025-03006-x.
3
Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders.
中枢神经系统疾病急性加重期肺部给药的机遇与挑战
CNS Drugs. 2025 Aug 7. doi: 10.1007/s40263-025-01213-4.
4
Association of Enterococcus faecalis and tyrosine decarboxylase gene levels with levodopa pharmacokinetics in Parkinson's disease.粪肠球菌和酪氨酸脱羧酶基因水平与帕金森病中左旋多巴药代动力学的关联
NPJ Parkinsons Dis. 2025 Mar 18;11(1):49. doi: 10.1038/s41531-025-00903-6.
5
Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's disease.吸入用左旋多巴干粉制剂对帕金森病患者关期的治疗效果。
Ther Adv Neurol Disord. 2024 Oct 25;17:17562864241289207. doi: 10.1177/17562864241289207. eCollection 2024.
6
Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics.帕金森病中连续多巴胺能疗法的效果:L-多巴药代动力学/药效学的综述。
J Parkinsons Dis. 2024;14(5):925-939. doi: 10.3233/JPD-230372.
7
Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease.胃充盈超声检查评估帕金森病患者的胃动力
Front Neurol. 2024 Feb 12;15:1294260. doi: 10.3389/fneur.2024.1294260. eCollection 2024.
8
Can Continuous Levodopa Delivery Be Achieved in the Absence of Intrajejunal Levodopa Infusion? Implications for India and Underserved Countries.在没有空肠内左旋多巴输注的情况下能否实现持续左旋多巴给药?对印度和医疗服务不足国家的启示。
Mov Disord Clin Pract. 2024 Jan;11(1):21-29. doi: 10.1002/mdc3.13915. Epub 2023 Nov 28.
9
Management of Gastrointestinal Symptoms in Parkinson's Disease: A Comprehensive Review of Clinical Presentation, Workup, and Treatment.帕金森病胃肠道症状的管理:临床特征、检查及治疗的全面综述。
J Clin Gastroenterol. 2024 Mar 1;58(3):211-220. doi: 10.1097/MCG.0000000000001961.
10
Impact of outpatient gastroenterology consult on pharmacotherapy and management of gastrointestinal symptoms in Parkinson's Disease.门诊胃肠病咨询对帕金森病药物治疗及胃肠道症状管理的影响
Clin Park Relat Disord. 2023 Aug 29;9:100215. doi: 10.1016/j.prdoa.2023.100215. eCollection 2023.